CliffsList
The Japan Advantage: From Introduction to Action - Advancing Global Drug Development with Japan
A session on Japan’s drug-development ecosystem featuring perspectives from Japanese agencies, venture capital, global pharma, and startups. Topics include regulatory programs, funding, collaboration opportunities, and ENSEMBLExJ activities.
AI summary · From the event listing
October 29, 2026 · 2:30 PM – 6 PM
LabCentral, Cambridge · Free ·
Keep your plans in one place. Free account.
Hear perspectives from Japanese drug-development agencies, cancer researchers, venture capital, pharma, and startups on entering and growing in Japan.
AI · From the event listing
Organizer’s description
October 29, 2026 Registration: 2:00 PM | Session: 2:30–6:00 PM LabCentral, 700 Main St, Cambridge, MA Join ENSEMBLExJ, a platform supporting global biotech companies seeking to enter and grow in Japan.Hear from National Cancer Center Japan (NCCJ), Pharmaceuticals and Medical Devices Agency (PMDA), Japan Agency for Medical Research and Development (AMED), venture capital, global pharma, and startups on Japan’s drug development ecosystem, including:▪ ENSEMBLExJ: Latest activities and opportunities▪ PMDA: Regulatory programs and support for drug development▪ AMED: Funding and collaboration opportunities▪ VC, Pharma & Startups: Perspectives on Japan’s biotech ecosystem Connect with key players and explore opportunities in Japan.We look forward to seeing you there! Learn more▼ https://docs.google.com/document/d/1-0JyhCEo8NwnmCfiGyKyBWrmzQW35WpDDAjSwmE9RZ4/edit?usp=sharing
Hosted by Hitomi
More like this